StartDate,EndDate,Status,IPAddress,Progress,Duration (in seconds),Finished,RecordedDate,ResponseId,RecipientLastName,RecipientFirstName,RecipientEmail,ExternalReference,LocationLatitude,LocationLongitude,DistributionChannel,UserLanguage,id,title,initials,design,strobe,strobe_4_TEXT,strobe_ev,strobe_cite,reg,reg_ev,reg_id,var_id,ukb_credit,ukb_credit_ev,strobe_1_5_1,strobe_1_5_2,strobe_1_5_3,strobe_1_5_3_TEXT,strobe_1_5_4,strobe_1_5_4_TEXT,strobe_1_5_5,strobe_1_5_5_TEXT,strobe_1_5_6,strobe_1_5_6_TEXT,strobe_1_5_7,strobe_1_5_7_TEXT,strobe_1_5_8,strobe_1_5_8_TEXT,strobe_1_5_9,strobe_1_5_9_TEXT,strobe_1_5_10,strobe_1_5_10_TEXT,strobe_1_5_11,strobe_1_5_11_TEXT,strobe_6_coh_1,strobe_6_coh_1_TEXT,strobe_6_coh_2,strobe_6_coh_2_TEXT,strobe_6_coh_3,strobe_6_coh_3_TEXT,strobe_6_coh_4,strobe_6_coh_4_TEXT,strobe_6_coh_5,strobe_6_coh_5_TEXT,strobe_6_coh_6,strobe_6_coh_6_TEXT,strobe_6_x_1,strobe_6_x_1_TEXT,strobe_6_x_2,strobe_6_x_2_TEXT,strobe_6_x_3,strobe_6_x_3_TEXT,strobe_6_cc_1,strobe_6_cc_1_TEXT,strobe_6_cc_2,strobe_6_cc_2_TEXT,strobe_6_cc_3,strobe_6_cc_3_TEXT,strobe_6_cc_4,strobe_6_cc_4_TEXT,strobe_6_cc_5,strobe_6_cc_5_TEXT,strobe_7_14_1,strobe_7_14_1_TEXT,strobe_7_14_2,strobe_7_14_2_TEXT,strobe_7_14_3,strobe_7_14_3_TEXT,strobe_7_14_4,strobe_7_14_4_TEXT,strobe_7_14_5,strobe_7_14_5_TEXT,strobe_7_14_6,strobe_7_14_6_TEXT,strobe_7_14_7,strobe_7_14_7_TEXT,strobe_7_14_8,strobe_7_14_9,strobe_7_14_10,strobe_7_14_10_TEXT,strobe_7_14_11,strobe_7_14_12,strobe_7_14_13,strobe_7_14_13_TEXT,strobe_7_14_14,strobe_7_14_15,strobe_7_14_16,strobe_7_14_16_TEXT,strobe_7_14_17,strobe_7_14_17_TEXT,strobe_7_14_18,strobe_7_14_18_TEXT,strobe_7_14_19,strobe_7_14_19_TEXT,strobe_7_14_20,strobe_7_14_20_TEXT,strobe_7_14_21,strobe_7_14_21_TEXT,strobe_7_14_22,strobe_7_14_22_TEXT,strobe_7_14_23,strobe_7_14_23_TEXT,strobe_7_14_24,strobe_7_14_24_TEXT,strobe_7_14_25,strobe_7_14_25_TEXT,strobe_7_14_26,strobe_7_14_26_TEXT,strobe_7_14_27,strobe_7_14_27_TEXT,strobe_7_14_28,strobe_7_14_28_TEXT,strobe_7_14_29,strobe_7_14_30,strobe_7_14_31,strobe_7_14_31_TEXT,strobe_7_14_32,strobe_7_14_33,strobe_7_14_34,strobe_7_14_34_TEXT,strobe_7_14_35,strobe_7_14_36,strobe_7_14_37,strobe_7_14_37_TEXT,strobe_7_14_38,strobe_7_14_39,strobe_7_14_40,strobe_7_14_40_TEXT,strobe_7_14_41,strobe_7_14_42,strobe_14_15_coh_1,strobe_14_15_coh_1_TEXT,strobe_14_15_coh_2,strobe_14_15_coh_3,strobe_14_15_coh_3_TEXT,strobe_14_15_coh_4,strobe_15_cc_1,strobe_15_cc_1_TEXT,strobe_15_cc_2,strobe_15_x_1,strobe_15_x_1_TEXT,strobe_15_x_2,strobe_16_22_1,strobe_16_22_1_TEXT,strobe_16_22_2,strobe_16_22_2_TEXT,strobe_16_22_3,strobe_16_22_3_TEXT,strobe_16_22_4,strobe_16_22_4_TEXT,strobe_16_22_5,strobe_16_22_5_TEXT,strobe_16_22_6,strobe_16_22_6_TEXT,strobe_16_22_7,strobe_16_22_7_TEXT,strobe_16_22_8,strobe_16_22_8_TEXT,strobe_16_22_9,strobe_16_22_9_TEXT,strobe_16_22_10,strobe_16_22_10_TEXT,strobe_16_22_11,strobe_16_22_11_TEXT,strobe_16_22_12,strobe_16_22_12_TEXT,strobe_16_22_13,strobe_16_22_13_TEXT,strobe_16_22_14,strobe_16_22_14_TEXT,strobe_16_22_15,strobe_16_22_15_TEXT,strobe_16_22_16,strobe_16_22_16_TEXT,strobe_16_22_17,strobe_16_22_17_TEXT
Start Date,End Date,Response Type,IP Address,Progress,Duration (in seconds),Finished,Recorded Date,Response ID,Recipient Last Name,Recipient First Name,Recipient Email,External Data Reference,Location Latitude,Location Longitude,Distribution Channel,User Language,"Article ID  	copy and paste in the article ID from the csv file 	close Excel",Copy and paste the article's title,Your initials,What study designs do the authors use to analyse the UK Biobank data?,"Did the authors state that they followed STROBE?   	search article & relevant supplementary material for all these terms: 'reporting' | 'guideline' | 'checklist' | 'STROBE' | 'followed' | 'equator') - Selected Choice","Did the authors state that they followed STROBE?   	search article & relevant supplementary material for all these terms: 'reporting' | 'guideline' | 'checklist' | 'STROBE' | 'followed' | 'equator') - Other reporting guidelines used - they state they used reporting guidelines other than STROBE. (please specify which reporting guidelines they said they used) - Text",Copy and paste in the authors statement regarding their use of reporting guidelines,If the authors do follow STROBE or other reporting guidelines do they cite these guidelines?,"Do the authors state that the studies contained in the article were registered?   	 search article & relevant supplementary material for all these terms: 'regist' | 'protocol' | 'plan' | 'publis')",Copy and paste in the authors' statement regarding registration,"Copy and paste in the registration's reference number, DOI or other identifier (leave blank if none provided)","Do the authors reference the UK Biobank ID numbers for all the variables?  	examine any very large numbers found in the methods, results and all supplementary material","The UK Biobank requires that any publication of results includes the following credit: “This research has been conducted using the UK Biobank Resource.”. Do the authors do this?  	search article & relevant supplementary material for all these terms: 'UK' | 'Resource'",Copy and paste the author's reference to the UK Biobank (if there are multiple references copy and paste the one that closest resembles “This research has been conducted using the UK Biobank Resource.”),Indicate if the authors report the following items - 1. (a) Indicate the study’s design with a commonly used term in the title or the abstract,Indicate if the authors report the following items - 1. (b) Provide in the abstract an informative and balanced summary of what was done and what was found,Indicate if the authors report the following items - 2. Explain the scientific background and rationale for the investigation being reported,Indicate if the authors report the following items - 2. Explain the scientific background and rationale for the investigation being reported - Text,"Indicate if the authors report the following items - 3. State specific objectives, including any prespecified hypotheses","Indicate if the authors report the following items - 3. State specific objectives, including any prespecified hypotheses - Text",Indicate if the authors report the following items - 4. Present key elements of study design early in the paper,Indicate if the authors report the following items - 4. Present key elements of study design early in the paper - Text,Indicate if the authors report the following items - 5. (i) Describe the setting,Indicate if the authors report the following items - 5. (i) Describe the setting - Text,Indicate if the authors report the following items - 5. (ii) Describe the locations,Indicate if the authors report the following items - 5. (ii) Describe the locations - Text,Indicate if the authors report the following items - 5. (iii) Describe the relevant dates including periods of recruitment,Indicate if the authors report the following items - 5. (iii) Describe the relevant dates including periods of recruitment - Text,Indicate if the authors report the following items - 5. (iv)  Describe the relevant dates including periods of exposure,Indicate if the authors report the following items - 5. (iv)  Describe the relevant dates including periods of exposure - Text,Indicate if the authors report the following items - 5. (v) Describe the relevant dates including periods of follow-up,Indicate if the authors report the following items - 5. (v) Describe the relevant dates including periods of follow-up - Text,Indicate if the authors report the following items - 5. (vi) Describe the relevant dates including periods of data collection,Indicate if the authors report the following items - 5. (vi) Describe the relevant dates including periods of data collection - Text,Indicate if the authors report the following items for the cohort studies included in the article - 6. (a) (i) Cohort study - Give the eligibility criteria,Indicate if the authors report the following items for the cohort studies included in the article - 6. (a) (i) Cohort study - Give the eligibility criteria - Text,Indicate if the authors report the following items for the cohort studies included in the article - 6. (a) (ii) Cohort study - Give the sources of participants,Indicate if the authors report the following items for the cohort studies included in the article - 6. (a) (ii) Cohort study - Give the sources of participants - Text,Indicate if the authors report the following items for the cohort studies included in the article - 6. (a) (iii) Cohort study - Give the methods of selection of participants,Indicate if the authors report the following items for the cohort studies included in the article - 6. (a) (iii) Cohort study - Give the methods of selection of participants - Text,Indicate if the authors report the following items for the cohort studies included in the article - 6. (a) (iv) Cohort study - Describe methods of follow-up,Indicate if the authors report the following items for the cohort studies included in the article - 6. (a) (iv) Cohort study - Describe methods of follow-up - Text,"Indicate if the authors report the following items for the cohort studies included in the article - 6. (b) (i) Cohort study - For matched studies, give matching criteria","Indicate if the authors report the following items for the cohort studies included in the article - 6. (b) (i) Cohort study - For matched studies, give matching criteria - Text","Indicate if the authors report the following items for the cohort studies included in the article - 6. (b) Cohort study - For matched studies, give number of exposed and unexposed","Indicate if the authors report the following items for the cohort studies included in the article - 6. (b) Cohort study - For matched studies, give number of exposed and unexposed - Text",Indicate if the authors report the following items for the cross-sectional studies included in the article - 6. (a) (i) Cross-sectional study - Give the eligibility criteria,Indicate if the authors report the following items for the cross-sectional studies included in the article - 6. (a) (i) Cross-sectional study - Give the eligibility criteria - Text,Indicate if the authors report the following items for the cross-sectional studies included in the article - 6. (a) (ii) Cross-sectional study - Give the sources of participants,Indicate if the authors report the following items for the cross-sectional studies included in the article - 6. (a) (ii) Cross-sectional study - Give the sources of participants - Text,Indicate if the authors report the following items for the cross-sectional studies included in the article - 6. (a) (iii) Cross-sectional study - Give the methods of selection of participants,Indicate if the authors report the following items for the cross-sectional studies included in the article - 6. (a) (iii) Cross-sectional study - Give the methods of selection of participants - Text,Indicate if the authors report the following items for the case-control studies included in the article - 6. (a) (i) Case-control study - Give the eligibility criteria,Indicate if the authors report the following items for the case-control studies included in the article - 6. (a) (i) Case-control study - Give the eligibility criteria - Text,Indicate if the authors report the following items for the case-control studies included in the article - 6. (a) (ii) Case-control study - Give the sources of case ascertainment and control selection,Indicate if the authors report the following items for the case-control studies included in the article - 6. (a) (ii) Case-control study - Give the sources of case ascertainment and control selection - Text,Indicate if the authors report the following items for the case-control studies included in the article - 6. (a) (iii) Case-control study - Give the methods of case ascertainment and control selection.,Indicate if the authors report the following items for the case-control studies included in the article - 6. (a) (iii) Case-control study - Give the methods of case ascertainment and control selection. - Text,Indicate if the authors report the following items for the case-control studies included in the article - 6. (a) (iv) Case-control study - Give the rationale for the choice of cases and controls,Indicate if the authors report the following items for the case-control studies included in the article - 6. (a) (iv) Case-control study - Give the rationale for the choice of cases and controls - Text,"Indicate if the authors report the following items for the case-control studies included in the article - 6. (b) Case-control study - For matched studies, give matching criteria and the number of controls per case","Indicate if the authors report the following items for the case-control studies included in the article - 6. (b) Case-control study - For matched studies, give matching criteria and the number of controls per case - Text",Indicate if the authors report the following items - 7. (i) Clearly define all outcomes,Indicate if the authors report the following items - 7. (i) Clearly define all outcomes - Text,Indicate if the authors report the following items - 7. (ii) Clearly define all exposures,Indicate if the authors report the following items - 7. (ii) Clearly define all exposures - Text,"Indicate if the authors report the following items - 7. (iii) Clearly define all predictors,","Indicate if the authors report the following items - 7. (iii) Clearly define all predictors, - Text",Indicate if the authors report the following items - 7. (iv) Clearly define all  potential confounders,Indicate if the authors report the following items - 7. (iv) Clearly define all  potential confounders - Text,Indicate if the authors report the following items - 7. (v) Clearly define all effect modifiers,Indicate if the authors report the following items - 7. (v) Clearly define all effect modifiers - Text,"Indicate if the authors report the following items - 7. (vi) Give diagnostic criteria, if applicable","Indicate if the authors report the following items - 7. (vi) Give diagnostic criteria, if applicable - Text","Indicate if the authors report the following items - 8*. (i) For each variable of interest, give sources of data","Indicate if the authors report the following items - 8*. (i) For each variable of interest, give sources of data - Text",Indicate if the authors report the following items - 8. (i) (*) Case-control studies - give the information separately for cases and controls,Indicate if the authors report the following items - 8. (i) (*) Cohort and cross-sectional studies - give the information separately for exposed and unexposed groups,"Indicate if the authors report the following items - 8*. (ii) For each variable of interest, give details of methods of assessment (measurement)","Indicate if the authors report the following items - 8*. (ii) For each variable of interest, give details of methods of assessment (measurement) - Text",Indicate if the authors report the following items - 8. (ii) (*) Case-control studies - give the information separately for cases and controls,Indicate if the authors report the following items - 8. (ii) (*) Cohort and cross-sectional studies - give the information separately for exposed and unexposed groups,Indicate if the authors report the following items - 8*. (iii) Describe comparability of assessment methods if there is more than one group,Indicate if the authors report the following items - 8*. (iii) Describe comparability of assessment methods if there is more than one group - Text,Indicate if the authors report the following items - 8. (iii) (*) Case-control studies - give the information separately for cases and controls,Indicate if the authors report the following items - 8. (iii) (*) Cohort and cross-sectional studies - give the information separately for exposed and unexposed groups,Indicate if the authors report the following items - 9. Describe any efforts to address potential sources of bias,Indicate if the authors report the following items - 9. Describe any efforts to address potential sources of bias - Text,Indicate if the authors report the following items - 10. Explain how the study size was arrived at,Indicate if the authors report the following items - 10. Explain how the study size was arrived at - Text,Indicate if the authors report the following items - 11. Explain how quantitative variables were handled in the analyses.,Indicate if the authors report the following items - 11. Explain how quantitative variables were handled in the analyses. - Text,"Indicate if the authors report the following items - 11. (ii) If applicable, describe which groupings were chosen","Indicate if the authors report the following items - 11. (ii) If applicable, describe which groupings were chosen - Text","Indicate if the authors report the following items - 11. (iii) If applicable, describe why groupings were chosen","Indicate if the authors report the following items - 11. (iii) If applicable, describe why groupings were chosen - Text","Indicate if the authors report the following items - 12. (a) Describe all statistical methods, including those used to control for confounding","Indicate if the authors report the following items - 12. (a) Describe all statistical methods, including those used to control for confounding - Text",Indicate if the authors report the following items - 12. (b) Describe any methods used to examine subgroups and interactions,Indicate if the authors report the following items - 12. (b) Describe any methods used to examine subgroups and interactions - Text,Indicate if the authors report the following items - 12. (c) Explain how missing data were addressed,Indicate if the authors report the following items - 12. (c) Explain how missing data were addressed - Text,"Indicate if the authors report the following items - 12. (d) Cohort study - If applicable, explain how loss to follow-up was addressed","Indicate if the authors report the following items - 12. (d) Cohort study - If applicable, explain how loss to follow-up was addressed - Text","Indicate if the authors report the following items - 12. (d) Case-control study—If applicable, explain how matching of cases and controls was addressed","Indicate if the authors report the following items - 12. (d) Case-control study—If applicable, explain how matching of cases and controls was addressed - Text","Indicate if the authors report the following items - 12. (d) Cross-sectional study—If applicable, describe analytical methods taking account of sampling strategy","Indicate if the authors report the following items - 12. (d) Cross-sectional study—If applicable, describe analytical methods taking account of sampling strategy - Text",Indicate if the authors report the following items - 12. (e) Describe any sensitivity analyses,Indicate if the authors report the following items - 12. (e) Describe any sensitivity analyses - Text,"Indicate if the authors report the following items - 13*. (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed","Indicate if the authors report the following items - 13*. (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed - Text",Indicate if the authors report the following items - 13. (a) (*) Case-control studies - give the information separately for cases and controls,Indicate if the authors report the following items - 13. (a) (*) Cohort and cross-sectional studies - give the information separately for exposed and unexposed groups,Indicate if the authors report the following items - 13*. (b) Give reasons for non-participation at each stage,Indicate if the authors report the following items - 13*. (b) Give reasons for non-participation at each stage - Text,Indicate if the authors report the following items - 13. (b) (*) Case-control studies - give the information separately for cases and controls,Indicate if the authors report the following items - 13. (b) (*) Cohort and cross-sectional studies - give the information separately for exposed and unexposed groups,Indicate if the authors report the following items - 13*. (c) Use a flow diagram,Indicate if the authors report the following items - 13*. (c) Use a flow diagram - Text,Indicate if the authors report the following items - 13. (c) (*) Case-control studies - give the information separately for cases and controls,Indicate if the authors report the following items - 13. (c) (*) Cohort and cross-sectional studies - give the information separately for exposed and unexposed groups,"Indicate if the authors report the following items - 14*. (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders","Indicate if the authors report the following items - 14*. (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders - Text",Indicate if the authors report the following items - 14. (a) (*) Case-control studies - give the information separately for cases and controls,Indicate if the authors report the following items - 14. (a) (*)  Cohort and cross-sectional studies - give the information separately for exposed and unexposed groups,Indicate if the authors report the following items - 14*. (b) Indicate number of participants with missing data for each variable of interest,Indicate if the authors report the following items - 14*. (b) Indicate number of participants with missing data for each variable of interest - Text,Indicate if the authors report the following items - 14. (b) (*) Case-control studies - give the information separately for cases and controls,Indicate if the authors report the following items - 14. (b) (*)  Cohort and cross-sectional studies - give the information separately for exposed and unexposed groups,"Indicate if the authors report the following items for the cohort studies included in the article - 14*. (c) Cohort study—Summarise follow-up time (eg, average and total amount)","Indicate if the authors report the following items for the cohort studies included in the article - 14*. (c) Cohort study—Summarise follow-up time (eg, average and total amount) - Text",Indicate if the authors report the following items for the cohort studies included in the article - 14. (c) (*)  Cohort studies - give the information separately for exposed and unexposed groups,Indicate if the authors report the following items for the cohort studies included in the article - 15. Cohort study—Report numbers of outcome events or summary measures over time,Indicate if the authors report the following items for the cohort studies included in the article - 15. Cohort study—Report numbers of outcome events or summary measures over time - Text,Indicate if the authors report the following items for the cohort studies included in the article - 15. (*) Cohort studies - give the information separately for exposed and unexposed groups,"Indicate if the authors report the following items for the case-control studies included in the article - 15*. Case-control study—Report numbers in each exposure category, or summary measures of exposure","Indicate if the authors report the following items for the case-control studies included in the article - 15*. Case-control study—Report numbers in each exposure category, or summary measures of exposure - Text",Indicate if the authors report the following items for the case-control studies included in the article - 15. (*) Case-control studies - give the information separately for cases and controls,Indicate if the authors report the following items for the cross-sectional studies included in the article - 15*. Cross-sectional study—Report numbers of outcome events or summary measures,Indicate if the authors report the following items for the cross-sectional studies included in the article - 15*. Cross-sectional study—Report numbers of outcome events or summary measures - Text,Indicate if the authors report the following items for the cross-sectional studies included in the article - 15. (*) Cross-sectional studies - give the information separately for exposed and unexposed groups,Indicate if the authors report the following items - 16. (a) (i) Give unadjusted estimates,Indicate if the authors report the following items - 16. (a) (i) Give unadjusted estimates - Text,"Indicate if the authors report the following items - 16. (a) (ii) If applicable, give confounder-adjusted estimates","Indicate if the authors report the following items - 16. (a) (ii) If applicable, give confounder-adjusted estimates - Text","Indicate if the authors report the following items - 16. (a) (iii) If applicable, give the confounder-adjusted estimates' precision (eg, 95% confidence interval)","Indicate if the authors report the following items - 16. (a) (iii) If applicable, give the confounder-adjusted estimates' precision (eg, 95% confidence interval) - Text",Indicate if the authors report the following items - 16. (a) (iv) Make clear which confounders were adjusted for,Indicate if the authors report the following items - 16. (a) (iv) Make clear which confounders were adjusted for - Text,Indicate if the authors report the following items - 16. (a) (v) Make clear why confounders were included,Indicate if the authors report the following items - 16. (a) (v) Make clear why confounders were included - Text,Indicate if the authors report the following items - 16. (b) Report category boundaries when continuous variables were categorized,Indicate if the authors report the following items - 16. (b) Report category boundaries when continuous variables were categorized - Text,"Indicate if the authors report the following items - 16.  (c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period","Indicate if the authors report the following items - 16.  (c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period - Text","Indicate if the authors report the following items - 17. Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses","Indicate if the authors report the following items - 17. Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses - Text",Indicate if the authors report the following items - 18. Summarise key results with reference to study objectives,Indicate if the authors report the following items - 18. Summarise key results with reference to study objectives - Text,"Indicate if the authors report the following items - 19. (i). Discuss limitations of the study, taking into account sources of potential bias or imprecision.","Indicate if the authors report the following items - 19. (i). Discuss limitations of the study, taking into account sources of potential bias or imprecision. - Text",Indicate if the authors report the following items - 19. (i) Discuss both direction and magnitude of any potential bias,Indicate if the authors report the following items - 19. (i) Discuss both direction and magnitude of any potential bias - Text,"Indicate if the authors report the following items - 20. Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence","Indicate if the authors report the following items - 20. Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence - Text",Indicate if the authors report the following items - 21. Discuss the generalisability (external validity) of the study results,Indicate if the authors report the following items - 21. Discuss the generalisability (external validity) of the study results - Text,Indicate if the authors report the following items - 22. (i) Give the source of funding for the present study,Indicate if the authors report the following items - 22. (i) Give the source of funding for the present study - Text,Indicate if the authors report the following items - 22. (ii) Give the the role of the funders for the present study,Indicate if the authors report the following items - 22. (ii) Give the the role of the funders for the present study - Text,"Indicate if the authors report the following items - 22. (iii)  If applicable, give the source of funding for the original study on which the present article is based","Indicate if the authors report the following items - 22. (iii)  If applicable, give the source of funding for the original study on which the present article is based - Text","Indicate if the authors report the following items - 22. (iv)  If applicable, give the role of the funders for the original study on which the present article is based","Indicate if the authors report the following items - 22. (iv)  If applicable, give the role of the funders for the original study on which the present article is based - Text"
"{""ImportId"":""startDate"",""timeZone"":""Europe/London""}","{""ImportId"":""endDate"",""timeZone"":""Europe/London""}","{""ImportId"":""status""}","{""ImportId"":""ipAddress""}","{""ImportId"":""progress""}","{""ImportId"":""duration""}","{""ImportId"":""finished""}","{""ImportId"":""recordedDate"",""timeZone"":""Europe/London""}","{""ImportId"":""_recordId""}","{""ImportId"":""recipientLastName""}","{""ImportId"":""recipientFirstName""}","{""ImportId"":""recipientEmail""}","{""ImportId"":""externalDataReference""}","{""ImportId"":""locationLatitude""}","{""ImportId"":""locationLongitude""}","{""ImportId"":""distributionChannel""}","{""ImportId"":""userLanguage""}","{""ImportId"":""QID1_TEXT""}","{""ImportId"":""QID5_TEXT""}","{""ImportId"":""QID18_TEXT""}","{""ImportId"":""QID114""}","{""ImportId"":""QID44""}","{""ImportId"":""QID44_4_TEXT""}","{""ImportId"":""QID45_TEXT""}","{""ImportId"":""QID108""}","{""ImportId"":""QID36""}","{""ImportId"":""QID47_TEXT""}","{""ImportId"":""QID39_TEXT""}","{""ImportId"":""QID113""}","{""ImportId"":""QID111""}","{""ImportId"":""QID112_TEXT""}","{""ImportId"":""QID75_4""}","{""ImportId"":""QID75_5""}","{""ImportId"":""QID75_8""}","{""ImportId"":""QID75_8_TEXT""}","{""ImportId"":""QID75_11""}","{""ImportId"":""QID75_11_TEXT""}","{""ImportId"":""QID75_12""}","{""ImportId"":""QID75_12_TEXT""}","{""ImportId"":""QID75_72""}","{""ImportId"":""QID75_72_TEXT""}","{""ImportId"":""QID75_14""}","{""ImportId"":""QID75_14_TEXT""}","{""ImportId"":""QID75_73""}","{""ImportId"":""QID75_73_TEXT""}","{""ImportId"":""QID75_74""}","{""ImportId"":""QID75_74_TEXT""}","{""ImportId"":""QID75_75""}","{""ImportId"":""QID75_75_TEXT""}","{""ImportId"":""QID75_76""}","{""ImportId"":""QID75_76_TEXT""}","{""ImportId"":""QID124_17""}","{""ImportId"":""QID124_17_TEXT""}","{""ImportId"":""QID124_86""}","{""ImportId"":""QID124_86_TEXT""}","{""ImportId"":""QID124_87""}","{""ImportId"":""QID124_87_TEXT""}","{""ImportId"":""QID124_88""}","{""ImportId"":""QID124_88_TEXT""}","{""ImportId"":""QID124_20""}","{""ImportId"":""QID124_20_TEXT""}","{""ImportId"":""QID124_94""}","{""ImportId"":""QID124_94_TEXT""}","{""ImportId"":""QID154_17""}","{""ImportId"":""QID154_17_TEXT""}","{""ImportId"":""QID154_86""}","{""ImportId"":""QID154_86_TEXT""}","{""ImportId"":""QID154_87""}","{""ImportId"":""QID154_87_TEXT""}","{""ImportId"":""QID134_18""}","{""ImportId"":""QID134_18_TEXT""}","{""ImportId"":""QID134_89""}","{""ImportId"":""QID134_89_TEXT""}","{""ImportId"":""QID134_90""}","{""ImportId"":""QID134_90_TEXT""}","{""ImportId"":""QID134_91""}","{""ImportId"":""QID134_91_TEXT""}","{""ImportId"":""QID134_21""}","{""ImportId"":""QID134_21_TEXT""}","{""ImportId"":""QID125_24""}","{""ImportId"":""QID125_24_TEXT""}","{""ImportId"":""QID125_86""}","{""ImportId"":""QID125_86_TEXT""}","{""ImportId"":""QID125_87""}","{""ImportId"":""QID125_87_TEXT""}","{""ImportId"":""QID125_88""}","{""ImportId"":""QID125_88_TEXT""}","{""ImportId"":""QID125_89""}","{""ImportId"":""QID125_89_TEXT""}","{""ImportId"":""QID125_91""}","{""ImportId"":""QID125_91_TEXT""}","{""ImportId"":""QID125_27""}","{""ImportId"":""QID125_27_TEXT""}","{""ImportId"":""QID125_101""}","{""ImportId"":""QID125_102""}","{""ImportId"":""QID125_93""}","{""ImportId"":""QID125_93_TEXT""}","{""ImportId"":""QID125_105""}","{""ImportId"":""QID125_106""}","{""ImportId"":""QID125_95""}","{""ImportId"":""QID125_95_TEXT""}","{""ImportId"":""QID125_107""}","{""ImportId"":""QID125_108""}","{""ImportId"":""QID125_29""}","{""ImportId"":""QID125_29_TEXT""}","{""ImportId"":""QID125_32""}","{""ImportId"":""QID125_32_TEXT""}","{""ImportId"":""QID125_35""}","{""ImportId"":""QID125_35_TEXT""}","{""ImportId"":""QID125_98""}","{""ImportId"":""QID125_98_TEXT""}","{""ImportId"":""QID125_99""}","{""ImportId"":""QID125_99_TEXT""}","{""ImportId"":""QID125_39""}","{""ImportId"":""QID125_39_TEXT""}","{""ImportId"":""QID125_40""}","{""ImportId"":""QID125_40_TEXT""}","{""ImportId"":""QID125_41""}","{""ImportId"":""QID125_41_TEXT""}","{""ImportId"":""QID125_110""}","{""ImportId"":""QID125_110_TEXT""}","{""ImportId"":""QID125_111""}","{""ImportId"":""QID125_111_TEXT""}","{""ImportId"":""QID125_112""}","{""ImportId"":""QID125_112_TEXT""}","{""ImportId"":""QID125_113""}","{""ImportId"":""QID125_113_TEXT""}","{""ImportId"":""QID125_114""}","{""ImportId"":""QID125_114_TEXT""}","{""ImportId"":""QID125_115""}","{""ImportId"":""QID125_120""}","{""ImportId"":""QID125_121""}","{""ImportId"":""QID125_121_TEXT""}","{""ImportId"":""QID125_122""}","{""ImportId"":""QID125_123""}","{""ImportId"":""QID125_124""}","{""ImportId"":""QID125_124_TEXT""}","{""ImportId"":""QID125_125""}","{""ImportId"":""QID125_126""}","{""ImportId"":""QID125_127""}","{""ImportId"":""QID125_127_TEXT""}","{""ImportId"":""QID125_128""}","{""ImportId"":""QID125_129""}","{""ImportId"":""QID125_130""}","{""ImportId"":""QID125_130_TEXT""}","{""ImportId"":""QID125_131""}","{""ImportId"":""QID125_132""}","{""ImportId"":""QID129_51""}","{""ImportId"":""QID129_51_TEXT""}","{""ImportId"":""QID129_94""}","{""ImportId"":""QID129_52""}","{""ImportId"":""QID129_52_TEXT""}","{""ImportId"":""QID129_96""}","{""ImportId"":""QID151_53""}","{""ImportId"":""QID151_53_TEXT""}","{""ImportId"":""QID151_98""}","{""ImportId"":""QID152_54""}","{""ImportId"":""QID152_54_TEXT""}","{""ImportId"":""QID152_98""}","{""ImportId"":""QID131_95""}","{""ImportId"":""QID131_95_TEXT""}","{""ImportId"":""QID131_106""}","{""ImportId"":""QID131_106_TEXT""}","{""ImportId"":""QID131_107""}","{""ImportId"":""QID131_107_TEXT""}","{""ImportId"":""QID131_108""}","{""ImportId"":""QID131_108_TEXT""}","{""ImportId"":""QID131_109""}","{""ImportId"":""QID131_109_TEXT""}","{""ImportId"":""QID131_96""}","{""ImportId"":""QID131_96_TEXT""}","{""ImportId"":""QID131_97""}","{""ImportId"":""QID131_97_TEXT""}","{""ImportId"":""QID131_98""}","{""ImportId"":""QID131_98_TEXT""}","{""ImportId"":""QID131_100""}","{""ImportId"":""QID131_100_TEXT""}","{""ImportId"":""QID131_101""}","{""ImportId"":""QID131_101_TEXT""}","{""ImportId"":""QID131_110""}","{""ImportId"":""QID131_110_TEXT""}","{""ImportId"":""QID131_102""}","{""ImportId"":""QID131_102_TEXT""}","{""ImportId"":""QID131_103""}","{""ImportId"":""QID131_103_TEXT""}","{""ImportId"":""QID131_105""}","{""ImportId"":""QID131_105_TEXT""}","{""ImportId"":""QID131_111""}","{""ImportId"":""QID131_111_TEXT""}","{""ImportId"":""QID131_112""}","{""ImportId"":""QID131_112_TEXT""}","{""ImportId"":""QID131_113""}","{""ImportId"":""QID131_113_TEXT""}"
18/09/2019 12:00,19/09/2019 10:25,IP Address,82.33.111.207,100,80682,TRUE,19/09/2019 10:25,R_1jfXqo4KJa2ZAiY,,,,,51.48779297,-2.624603271,anonymous,EN-GB,1,Arterial stiffness association with chronic inflammatory disorders in the UK Biobank study,MG,6,NI -the authors made no statement regarding their use of reporting guidelines,,,,NI - no statement regarding registration,,,Never,"Yes - almost exact wording (e.g. ""This work was conducted with the UK Biobank Resource, we conducted this research using the UK Biobank Resource"", ""This work used the UKB Resource"", ""This work was conducted using the UK Biobank"")",The data for the present study come from the UK Biobank.,NI,Yes,Partial,,Yes,"End of Intro. Main article, pp. 1 Col 2",NI,,Partial,,NA,,NA,,NI,,NA,,Yes,"In abstract, Para 2",Yes,"Main Article, pp. 2, Col 1, Para 2",Yes,"ain Article, pp. 1, Col 1, Para 2",Yes,"ain Article, pp. 2, Col 1, Para 2",NA,,NA,,NA,,,,,,,,,,,,,,,,,,Yes,"ain Article, pp. 2, Col 1, Para 3",Partially,"Main Article, pp. 2, Col 1, Para 4",NA,,Yes,"Main Article, pp. 2, Col 1, Para 5",NA,,Partially,"ain Article, pp. 2, Col 1, Para 2",Yes,"Main Article, pp. 1, Col 1, Para 2",,,Yes,"Main Article, pp. 2, Col 1, Para 4",,,NA,,,,Yes,"Main Article, pp. 2, Col 1, Para 5",Yes,"Main Article, pp. 2, Col 1, Para 2",Yes,"Main Article, pp. 2, Col 2, Para 2",Yes,"Main Article, pp. 2, Col 2, Para 2",Yes,"Main Article, pp. 2, Col 2, Para 2",Yes,"Main Article, pp. 2, Col 2, Para 2",Yes,"Main Article, pp. 2, Col 2, Para 2",Partially,"Main Article, pp. 2, Col 2, Para 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,"Main Article, pp 2, col 2, para 4 - pp.2",Yes,"Main Article, pp 2, col 2, para 4 - pp.2",Yes,"Main Article, pp 2, col 2, para 4 - pp.2",Yes,"Main Article, pp 2, col 1, para 5",NI,,NI,,Unsure,,Yes,"Main Article, pp 3, col 2, para 1",Yes,"Main Article, pp 4, col 1, para 2",Yes,"ain Article, pp 5, col 1, para 3",Yes,"Main Article, pp 5, col 1, para 3",Yes,"Main Article, pp 4 - pp5",Yes,"Main Article, pp 4 - pp5",Yes,"Main Article, pp 6, col 1, para 3",Yes,"Main Article, pp 6, col 1, para 3",Unsure,,Unsure,
19/09/2019 12:54,19/09/2019 16:29,IP Address,137.222.61.79,100,12906,TRUE,19/09/2019 16:29,R_290oai61GLfi8wp,,,,,51.45350647,-2.591705322,anonymous,EN-GB,2,Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants,MG,Cohort,Yes - the authors state that they followed the STROBE guidelines,,"""All analyses were planned before inspection of the data in keeping with STROBE guidelines."" (not cited in typical way but put link to STROBE website included at the side of the page)",Yes,NI - no statement regarding registration,,,Never,"No - the authors mention they used data from the UK Biobank but do not explictly credit it (e.g. our sample included 100,000 participants from the UK Biobank)",This study had ethical approval and is part of UK Biobank project 14151 (NHS National Research Ethics Service 16/NW/0274),Yes,Yes,Yes,Intro,Yes,End of Intro,Yes,Beginning of Methods,Partial,Methods,Yes,Beginning of Methods,Yes,Beginning of Methods,Unsure,,Partial,Outcomes,Partial,Beginning of Methods,Partially,Beginning of Methods,Yes,Beginning of Methods,NI,,Yes,Outcomes,NA,,NA,,,,,,,,,,,,,,,,,,Yes,outcomes,Yes,procedures,Yes,procedures,Yes,procedures,NA,,NA,,Yes,methods,,,Yes,Methods,,,NA,,,,Yes,statistical analysis,NI,,Yes,statistical analysis and Results,Yes,Procedures,Yes,Procedures,Yes,statistical analysis and Results,Yes,Statistical Analysis,Yes,"Procedures, Statistical Analysis and Results",,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,Outcomes,,Yes,Results,,,,,,,,External,Appendix,Yes,Results,Yes,Results,Yes,Statistical Analysis,NI,,Partially,Results,Unsure,,Unsure,,Yes,Discussion,Yes,Discussion,Yes,Discussion,Yes,Discussion,Yes,Discussion,Yes,Acknowledgements ,Yes,Acknowledgements ,Unsure,,Unsure,
20/09/2019 08:26,20/09/2019 09:37,IP Address,86.147.96.104,100,4299,TRUE,20/09/2019 09:37,R_2vdDVOrSUVw8aZR,,,,,51.47689819,-2.556106567,anonymous,EN-GB,1,Arterial stiffness association with chronic inflammatory disorders in the UK Biobank study,RR,6,NI -the authors made no statement regarding their use of reporting guidelines,,,,NI - no statement regarding registration,,,Never,"Yes - almost exact wording (e.g. ""This work was conducted with the UK Biobank Resource, we conducted this research using the UK Biobank Resource"", ""This work used the UKB Resource"", ""This work was conducted using the UK Biobank"")",This study has been conducted using the UK Biobank resource.,NI,Yes,Yes,"article, page 1, para 5",Yes,"article, page 1, para 5",Partial,"article, page 2, para 2",Yes,"article, page 1, para 6",Partial,"article, page 1, para 6",Partial,"article, page 1, para 2",NI,,NI,,Partial,"article, page 2, para 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yes,"article, page 2, para 3",Partially,"article, page 2, para 4",NA,,Partially,"article, page 2, para 5",NA,,NA,,Partially,"article, page 2, para 2-4",,,Partially,"article, page 2, para 2-4",,,NA,,,,Partially,"article, page 2, para 2; article, page 2, para 5; article, page 2, para 6",Yes,"article, page 2, para 2; article, page 2, para 7",Partially,"article, page 2, para 3-5",Partially,"article, page 2, para 4-5",NI,,Partially,"article, page 2, para 6",Yes,"article, page 2, para 6",Partially,"article, page 2, para 6",,,,,,,,,,,,,,,,,,,,,,,,,,,,,NA,,,NA,,,,,,,,,Yes,"article, page 2, para 8; article, page 3, figure 1",Yes,"article, page 2, para 8; article, page 3, figure 2; article, page 2, para 8; article, page 4, table 2 and 3",Yes,"article, page 2, para 8; article, page 4, table 2 and 3",Partially,"article, page 2, para 6",Partially,"article, page 2, para 5",NI,,NA,,Partially,"article, page 2, para 9; article, page 3, para 2; article, page 3, para 3; article, page 4, table 2 and 3",Yes,"article, page 4, para 2",Partially,"article, page 5, para 2",NI,,Partially,"article, page 5, para 4",Partially,"article, page 5, para 3",Yes,"article, page 6, para 3 ",NI,,NA,,NA,
20/09/2019 13:06,20/09/2019 13:53,IP Address,137.222.60.76,100,2798,TRUE,20/09/2019 13:53,R_2ZWx04I4sQlXiTo,,,,,51.45350647,-2.591705322,anonymous,EN-GB,1,Arterial stiffness association with chronic inflammatory disorders in the UK Biobank study,KD,6,NI -the authors made no statement regarding their use of reporting guidelines,,,,NI - no statement regarding registration,,,Never,Yes - exact wording (i.e. “This research has been conducted using the UK Biobank Resource.”),This study has been conducted using the UK Biobank resource,NI,Yes,Unsure,article; page 1; text before Methods,Yes,article; page 1; last paragraph before Methods,NI,article; page 1-2,16,article; page 2,16,article; page 1-2; Methods Data section,16,article; page 1-2; Methods Data section,16,article; page 1-2; Methods Data section,16,article; page 1-2; Methods Data section,16,article; page 1-2; Methods Data section,,,,,,,,,,,,,,,,,,,,article; page 2; Methods Data section; para 2,NI,article; page 2; Methods Data section; para 2,NI,article; page 2; Methods Data section; para 2,Partially,article; page 2; Methods Data section; para 2,NA,,Yes,article; page 2; Arterial stiffness outcomes section,,article; page 2; Exposures heading,NA,,Partially,article; page 2; covariates heading,NA,,Partially,article; page 2; Arterial stiffness outcomes section,Yes,article; page 1-2; Data section,,,Yes,article; page 2; Arterial stiffness outcomes section,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
